Journal of Surgical Research
Volume 141, Issue 1 , Pages 53-59 , July 2007

Elevated Levels of Chemokine Receptor CXCR4 in HER-2 Negative Breast Cancer Specimens Predict Recurrence

  • Neal T. Holm, M.D.

      Affiliations

    • Department of Surgery, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • ,
  • Kerry Byrnes, M.D.

      Affiliations

    • Department of Surgery, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • ,
  • Benjamin D.L. Li, M.D.

      Affiliations

    • Department of Surgery, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • ,
  • Richard H. Turnage, M.D.

      Affiliations

    • Department of Surgery, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • ,
  • Fleurette Abreo, M.D.

      Affiliations

    • Department of Pathology, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • ,
  • James M. Mathis, Ph.D.

      Affiliations

    • Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • ,
  • Quyen D. Chu, M.D.

      Affiliations

    • Department of Surgery, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center; Shreveport, Louisiana
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Louisiana State University Health Sciences Center and the Feist-Weiller Cancer Center, 1501 Kings Highway, Shreveport, LA 71130-3932.

Received 8 January 2007

References 

  1. Jemal A, Murray T, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin. 2005;55:10
  2. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177
  3. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783
  4. Weidner N, Cady B, Goodson WH. Pathologic prognostic factors for patients with breast carcinoma (Which factors are important?). Surg Oncol Clin N Am. 1997;6:415
  5. Jatoi I, Hilsenbeck S, Clark G, Osborne K. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol. 1999;17:2334
  6. Chambers A. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563
  7. Walser T. The role of chemokines in the biology and therapy of breast cancer. Breast Dis. 2004;20:137
  8. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metast Rev. 2006;25:357
  9. Proudfoot A. Chemokine receptors: Multifaceted therapeutic targets. Nat Rev Immunol. 2002;2:106
  10. Li Y, Pan Y. Up-regulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell. 2004;6:459
  11. Müller A, Homey B, Soto H, Ge N, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50
  12. Ottaiano A. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stages II-III colorectal cancer patients. Clin Cancer Res. 2006;12:2795
  13. Murakami T, Maki W. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 2002;62:7328
  14. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer. 1997;80:1529
  15. Lee B, Lee T, Avraham S, Avraham H. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells. Molec Cancer Res. 2004;6:327
  16. Liang Z, Yoon Y, Votaw J, et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 2005;65:967
  17. Lapteva N, Yang A, Sanders D, et al. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther. 2005;12:84
  18. Smith M, Luker K, Garbow J, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004;64:8604
  19. Benovic JL, Marchese A. A new key in breast cancer metastasis. Cancer Cell. 2004;6:429
  20. Marchese A, Railborg C, Santini F, et al. The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev Cell. 2003;5:709
  21. Kato M, Kitayama J, Kazama S, et al. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 2003;5:144
  22. Kang H, Watkins G, Douglas-Jones A, et al. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast. 2005;14:360
  23. Cabioglu N, Sahin A, Doucet M, et al. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis. 2005;22:39
  24. Cabioglu N, Yazici M, Arun B, et al. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res. 2005;11:5686
  25. McClusky DR, Chu QD, Yu H, DeBenedetti A, et al. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer. Ann Surg. 2005;242:584

PII: S0022-4804(07)00162-X

doi: 10.1016/j.jss.2007.03.015

Journal of Surgical Research
Volume 141, Issue 1 , Pages 53-59 , July 2007

Article Tools

* Image Usage & Resolution